This panel will explore how obesity should be understood, diagnosed and managed as part of integrated CVRM care.

Panellists will discuss the difference between obesity as a risk factor, a preclinical condition and an active disease, emphasising the need for precise, personalised assessment rather than blanket assumptions.

The discussion will cover clinical assessment, including respectful communication, measures beyond BMI, organ function and physical, mental and social impacts. Finally, speakers will consider longer-term support, nutrition, behaviour change and the role of GLP-1 medications. Delegates will leave with a framework for assessment, more patient-centred language and practical approaches to individualised patient care.